Literature DB >> 34645967

Should we still be performing macular laser for non-centre involving diabetic macular oedema? Yes.

Dinah Zur1, Anat Loewenstein2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34645967      PMCID： PMC8873465          DOI： 10.1038/s41433-021-01793-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.

Authors:  Diana V Do; Quan D Nguyen; Afsheen A Khwaja; Roomasa Channa; Yasir J Sepah; Raafay Sophie; Gulnar Hafiz; Peter A Campochiaro
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

2.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

3.  Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting.

Authors:  Anne-Laurence Best; Franck Fajnkuchen; Sylvia Nghiem-Buffet; Typhaine Grenet; Gabriel Quentel; Corinne Delahaye-Mazza; Salomon Y Cohen; Audrey Giocanti-Aurégan
Journal:  J Ophthalmol       Date:  2018-04-18       Impact factor: 1.909
  3 in total
  1 in total

1.  Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology.

Authors:  Noura Al Qassimi; Igor Kozak; Maysoon Al Karam; Piergiorgio Neri; Patricio M Aduriz-Lorenzo; Alaa Attawan; Mohamed Awadalla; Ahmed El Khashab; Mohamed Abdul-Nabi; Ammar Safar; Hanan Al Shamsi; Prasan Rao; Madhav Rao; Amr Farid; Avinash Gurbaxani
Journal:  Ophthalmol Ther       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.